Fairmount Funds Management LLC: 13F holdings
CIK 18025282026Q2
| Positions | 12 |
|---|
| Reported value | $1.5bn |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 12 (+0 vs prior quarter) |
|---|
| Reported value | $1.5bn (+9.3%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| ORKA ORUKA THERAPEUTICS INC | 3,705,262 | $352.6m | 23.3% |
| DNTH DIANTHUS THERAPEUTICS INC | 2,537,191 | $247.3m | 16.3% |
| DAMORA THERAPEUTICS INC | 8,713,000 | $226.6m | 15.0% |
| COGT COGENT BIOSCIENCES INC | 5,503,418 | $213.0m | 14.1% |
| JBIO JADE BIOSCIENCES INC | 4,553,494 | $101.2m | 6.7% |
| ELVN ENLIVEN THERAPEUTICS INC | 1,855,644 | $94.2m | 6.2% |
| VRDN VIRIDIAN THERAPEUTICS INC | 5,090,928 | $93.5m | 6.2% |
| ZBIO ZENAS BIOPHARMA INC | 2,359,025 | $59.9m | 4.0% |
| CRESCENT BIOPHARMA INC. | 2,747,866 | $49.5m | 3.3% |
| APOGEE THERAPEUTICS INC | 298,647 | $39.6m | 2.6% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1802528")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples